Article Details

US FDA Accepts for Priority Review the Biologics License Application for Pfizer's Investigational 20 ...

Retrieved on: 2020-12-08 22:18:29

Tags for this article:

Click the tags to see associated articles and topics

US FDA Accepts for Priority Review the Biologics License Application for Pfizer's Investigational 20 .... View article details on hiswai:

Excerpt

<b>Pfizer's</b> 20vPnC vaccine candidate includes capsular polysaccharide conjugates for the 13 serotypes already included in Prevnar 13<sup>®</sup> (Pneumococcal ...

Article found on: www.pfizer.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up